Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets

Transfusion

Volumn 46, Issue 11, 2006, Pages 1943-1950

  Fischer, Thomas H ^a   Bode, Arthur P ^b   Parker, Benjamin R ^b   Russell, Karen E ^b   Bender, Diane E ^b   Ramer, J Kevin ^b   Read, Marjorie S ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB; INTEGRIN; PROTEINASE ACTIVATED RECEPTOR; PROTHROMBIN; THROMBIN; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CELL ADHESION; CELL FUNCTION; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRIN CLOT; FREEZING; HEMOSTASIS; HUMAN; LYOPHILISATE; REHYDRATION; THROMBOCYTE; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA;

BLOOD COAGULATION; BLOOD LOSS, SURGICAL; BLOOD PLATELETS; BLOOD PRESERVATION; CARDIOPULMONARY BYPASS; FREEZE DRYING; HUMANS; INTEGRINS; MODELS, ANIMAL; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; PLATELET TRANSFUSION; RECEPTORS, CELL SURFACE; RECEPTORS, THROMBIN; THROMBIN; THROMBIN TIME;

EID: 33750335053     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.01002.x     Document Type: Article

References (36)

1. Bode AP. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 1990;16:109-25; discussion 25-6.
2. Blajchman M. Reducing the risk of bacterial contamination of cellular blood components. Dev Biol Stand 2000;102:183-93.
3. Read MS, Reddick RL, Bode AP, et al. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci U S A 1995;92:397-401.
4. Bode A, Blajchman M, Bardossy L, Read M. Hemostatice properties of human lyphilized platelets in a thrombocytopenic rabbit model and a simulated bleeding time device. Blood 1994;84(Suppl 1):464a.
5. Fischer TH, Merricks E, Raymer R, et al. The co-infusion of rehydrated lyopholized platelets wth HBOC-201 for hemostasis in dilutional thrombocytopenia. Blood 2001;98:2250.
6. Bode AP, Read MS, editors. Lyophilized platelets for transfusion. Amsterdam: Elserier Science; 2001.
7. Slichter S. Controversies in platelet transfusion: is prophylactic better than therapeutic transfusion therapy? Annu Rev Med 1980;31:509.
8. Slichter SA, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol 1978;7:523-39.
9. Pisciotto PT, Benson K, Hume H, et al. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995;35:498-502.
10. Fischer TH, Merricks EP, Bode AP, et al. Thrombus formation with rehydrated, lyophilized platelets. Hematology 2002;7:359-69.
11. Fischer TH, Merricks E, Bellinger DA, et al. Splenic clearance mechanisms of rehydrated, lyophilized platelets. Artif Cells Blood Substit Immobil Biotechnol 2001;29:439-51.
12. National Center for Health Statistics. 1999 national hospital discharge survey: annual summary with detailed diagnosis and procedure data [monograph on the Internet]. Atlanta (GA): Centers for Disease Control; 1999. Available from: http://www.cdc.gov/nchs/products/pubs/pubd/series/sr13/160-151/sr13_151.htm
13. Terrell DR, Williams LA, Vesely SK, et al. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost 2005;3:1432-6.
14. Read MS, Reddick R, Bode A. Pharmaceutically acceptable fixed-dried human blood platelets. Chapel Hill and Greenville: University of North Carolina at Chapel Hill and East Carolina University; 1995.
15. Summaria L, Roth N, Berhe A, Evans M. Method for prepring a diafiltered stabilized blood product. King of Prussia (PA): Aventis Behring, LLC; 2000.
16. Mazurier C, editor. Purification, biochemistry and structure/function of von Willebrand factor. London: CRC Press; 1989.
17. Fischer TH, Khandelwas G, Merricks E, et al.Thrombus formation and lysis with rehydrated, lyophilized platelets. Hematology 2002;7:359-69.
18. Fenton JW 2nd, Fasco MJ, Stackrow AB. Human thrombins: production, evaluation, and properties of alpha-thrombin. J Biol Chem 1977:3587-98.
19. Whitton C, Sands D, Lee T, et al. A reunification of the US ("NIH") and International Unit into a single standard for thrombin. Thromb Haemost 2005:261-6.
20. Dong JF, Berndt MC, Schade A, et al. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Blood 2001;97:162-8.
21. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22:1381-9.
22. Bode AR, Read MS. Lyophilized platelets for transfusion. In: Seghatchian J, editor. Platelet therapy: current status and future challenges. Amsterdam: Elsevier Science; 2001. p. 132-67.
23. Valeri CR, MacGregor H, Barnard MR, et al. Survival of baboon biotin-X-N-hydroxysuccinimide and (111)In-oxine-labelled autologous fresh and lyophilized reconstituted platelets. Vox Sang 2005;88:122-9.
24. Fischer TH, Merricks EP, Russell KE, et al. Intracellular function in rehydrated lyophilized platelets. Br J Haematol 2000;111:167-74.
25. Bode A, Read M, Reddick R. Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber. J Lab Clin Med 1999;133:200-11.
26. Langer S, Nolte D, Koeller M, et al. In vivo visualization of platelet/endothelium cell interaction in muscle flaps. Ann Plast Surg 2004;53:137-40.
27. Manegold PC, Hutter J, Pahernik SA, et al. Platelet-endothelial interaction in tumor angiogenesis and microcirculation. Blood 2003;101:1970-6.
28. Singer G, Urakami H, Specian RD, et al. Platelet recruitment in the murine hepatic microvasculature during experimental sepsis: role of neutrophils. Microcirculation 2006;13:89-97.
29. Massberg S, Enders G, Leiderer R, et al. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 1998;92:507-15.
30. Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005;115:3363-9.
31. Bode A, Read M, Summaria L. Lyophilized platelets: nearing clin trials. Platelets 1997;8:436-7.
32. Harding SA, Shakoor MA, Grindon AJ. Platelet support for cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg 1975;70:350-3.
33. Simon T, Akl B, Murphy W. Controlled trial for routine adminstration of platelet concentrates in cardiopulomary bypass surgery. Ann Thorac Surg 1984;37:359-69.
34. Premaratne S, Razzuk AM, Premaratne DR, et al. Effects of platelet transfusion on post cardiopulmonary bypass bleeding. Jpn Heart J 2001;42:425-33.
35. Vaslef S, Knudsen N, Neligan P, Sebastian M. Massive transfusion exceeding 50 units of blood products in trauma patients. J Trauma 2002;53:291-6.
36. Horsey PJ. Multiple trauma and massive transfusion. Anaesthesia 1997;52:1027-9.